Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28918401 | 0.78 | CTSK (0.40) | CTSKTSHR | |
| SCHEMBL4190031 | 0.71 | LMNA (0.40) | — | |
| SCHEMBL2129127 | 0.67 | TSHR (0.51) | CTSKTSHR | |
| SCHEMBL6432728 | 0.66 | DNM1 (0.36) | CTSKTSHR | |
| SCHEMBL14195883 | 0.66 | CTSK (0.39) | CTSKTSHR | |
| SCHEMBL5951659 | 0.66 | PCSK9 (0.46) | CTSK | |
| SCHEMBL1271235 | 0.66 | CTSK (0.36) | CTSKTSHR | |
| SCHEMBL27856287 | 0.66 | LMNA (0.43) | — | |
| SCHEMBL10672112 | 0.66 | ALDH1A1 (0.38) | CTSKTSHR | |
| SCHEMBL17655298 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118969605-A | Sidewall doping method of 3D memory device | 成都皮兆永存科技有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-107935456-A | A kind of the hydrophobicity artificial stone and its preparation process of the enhancing of response type silicon powder | 绩溪县黄山石英有限公司 | 2018-04-20 | — | — | CN | claimed |
| US-20180086913-A1 | GELS AND HYDROGELS AND SEED | MOASIS INC (US) | 2018-03-29 | — | — | US | claimed |
| US-9850379-B2 | Gels and hydrogels | CARBON NEUTRAL AG SCIENCES, LLC | 2017-12-26 | — | — | US | claimed |
| US-9422502-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-08-23 | — | — | US | claimed |
| CN-103429643-B | Gel and hydrogel | 贸森斯有限公司 | 2016-07-06 | — | — | CN | claimed |
| CN-104995237-A | Porous gel and application thereof | MOASIS INC | 2015-10-21 | — | — | CN | claimed |
| WO-2015153022-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-08 | — | — | WO | claimed |
| US-20150275128-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-10-01 | — | — | US | claimed |
| US-20150225646-A1 | POROUS GELS AND USES THEREOF | MOASIS INC (US) | 2015-08-13 | — | — | US | claimed |
| EP-2890730-A1 | POROUS GELS AND USES THEREOF | Moasis Inc. (US) | 2015-07-08 | — | — | EP | claimed |
| WO-2014032189-A1 | POROUS GELS AND USES THEREOF | MOASIS INC. (US) | 2014-03-06 | — | — | WO | claimed |
| US-20130303665-A1 | GELS AND HYDROGELS | CARBON NEUTRAL AG SCIENCES, LLC | 2013-11-14 | — | — | US | claimed |
| EP-2638101-A2 | GELS AND HYDROGELS | Moasis Inc. (US) | 2013-09-18 | — | — | EP | claimed |
| US-20130059210-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2013-03-07 | — | — | US | claimed |
| WO-2012064787-A2 | GELS AND HYDROGELS | W&L POLYMERS, LTD. (CA) | 2012-05-18 | — | — | WO | claimed |
| EP-4706654-A2 | CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | Amgen Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4164748-B1 | CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | AMGEN INC (US) | 2025-11-12 | — | — | EP | disclosed |
| WO-2004069133-A2 | N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI -CANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-19 | — | — | WO | disclosed |
| US-20040157841-A1 | inhibition of histone deacetylase; for inhibiting cell proliferation; cancer therapy | HOFFMANN-LA ROCHE INC. | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157841-A1 | inhibition of histone deacetylase; for inhibiting cell proliferation; cancer therapy | HDAC1, HDAC11, HDAC7 | CTSK 2726/4885TSHR 3315/4885 |
| US-20150275128-A1 | LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS | F12, OR10J3, ATXN10 | CTSK 2494/4885TSHR 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.